United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last?Zacks Investment Research • 03/31/26
United Therapeutics Tops A Buy Zone After Entering A 'New Era' With Phase 3 Home RunInvestors Business Daily • 03/30/26
United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso® Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2Business Wire • 03/30/26
United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/27/26
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show ResilienceInvestors Business Daily • 03/20/26
United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of MedicineBusiness Wire • 03/11/26
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade)Seeking Alpha • 03/11/26
United Therapeutics (UTHR) Surges 10.7%: Is This an Indication of Further Gains?Zacks Investment Research • 03/10/26
United Therapeutics Corporation (UTHR) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha • 03/09/26
United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase ProgramBusiness Wire • 03/09/26
United Therapeutics Corporation to Present at the Leerink Global Healthcare ConferenceBusiness Wire • 03/03/26
United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference TranscriptSeeking Alpha • 03/02/26
United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension TranscriptSeeking Alpha • 03/02/26
United Therapeutics' blood pressure drug meets main, secondary goals in late-stage studyReuters • 03/02/26
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant EfficacyBusiness Wire • 03/02/26
These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 EarningsBenzinga • 02/26/26
United Therapeutics Q4 Earnings: Sky May Be The Limit For This Management TeamSeeking Alpha • 02/26/26
UTHR Tops Q4 Earnings Estimates, Shares Surge 13% on Strong GuidanceZacks Investment Research • 02/26/26
Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/25/26